DMXAA (ASA404)

5,6-dimethylxanthenone-4-acetic acid · Antisoma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DMXAA (ASA404), covering 2009-01-30 to 2009-01-30. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study of DMXAA (ASA404) in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]

See pricing